Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Netarsudil in Japanese/Japanese-American subjects with OAG or OHT
NCT03310580Phase 2Completed
- Sponsor
- Aerie Pharmaceuticals
- Start
- Nov 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of netarsudil in open-angle glaucoma (OAG), ocular hypertension, sponsored by Aerie Pharmaceuticals. Started Nov 2017; status: completed.
02
Drugs
netarsudil
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT03310580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03310580.